Korenromp IH - Search Results

1

Health-related quality of life in sarcoidosis.

Korenromp IH, van de Laar MA. Korenromp IH, et al. Curr Opin Pulm Med. 2014 Sep;20(5):503-7. doi: 10.1097/MCP.0000000000000079. Curr Opin Pulm Med. 2014. PMID: 25013952 Review.

2

Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis.

Vis R, van de Garde EMW, Meek B, Korenromp IHE, Grutters JC. Vis R, et al. Among authors: korenromp ihe. Respir Med. 2020 Apr-May;165:105936. doi: 10.1016/j.rmed.2020.105936. Epub 2020 Mar 16. Respir Med. 2020. PMID: 32308204 Free article. Clinical Trial.

3

The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review.

Vis R, van de Garde EMW, Grutters JC, Korenromp IHE. Vis R, et al. Among authors: korenromp ihe. Eur Respir Rev. 2020 Jan 29;29(155):190057. doi: 10.1183/16000617.0057-2019. Print 2020 Mar 31. Eur Respir Rev. 2020. PMID: 31996355 Free PMC article.

4

Characterization of chronic fatigue in patients with sarcoidosis in clinical remission.

Korenromp IHE, Heijnen CJ, Vogels OJM, van den Bosch JMM, Grutters JC. Korenromp IHE, et al. Chest. 2011 Aug;140(2):441-447. doi: 10.1378/chest.10-2629. Epub 2011 Feb 17. Chest. 2011. PMID: 21330380

5

Post-inflammatory fatigue in sarcoidosis: personality profiles, psychological symptoms and stress hormones.

Korenromp IH, Grutters JC, van den Bosch JM, Heijnen CJ. Korenromp IH, et al. J Psychosom Res. 2012 Feb;72(2):97-102. doi: 10.1016/j.jpsychores.2011.10.001. Epub 2011 Nov 8. J Psychosom Res. 2012. PMID: 22281449

6

Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue.

Korenromp IH, Grutters JC, van den Bosch JM, Zanen P, Kavelaars A, Heijnen CJ. Korenromp IH, et al. Brain Behav Immun. 2011 Oct;25(7):1498-502. doi: 10.1016/j.bbi.2011.06.004. Epub 2011 Jun 13. Brain Behav Immun. 2011. PMID: 21693184

7

Anti-TNF therapeutics for the treatment of sarcoidosis.

Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC. Crommelin HA, et al. Among authors: korenromp ih. Immunotherapy. 2014;6(10):1127-43. doi: 10.2217/imt.14.65. Immunotherapy. 2014. PMID: 25428650 Review.

8

Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis?

Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC. Crommelin HA, et al. Among authors: korenromp ih. Immunotherapy. 2015;7(6):601. doi: 10.2217/imt.15.25. Epub 2015 Jun 22. Immunotherapy. 2015. PMID: 26098292 Free article. No abstract available.

9

FDG PET for gauging of sarcoid disease activity.

Adams H, Keijsers RG, Korenromp IH, Grutters JC. Adams H, et al. Among authors: korenromp ih. Semin Respir Crit Care Med. 2014 Jun;35(3):352-61. doi: 10.1055/s-0034-1376866. Epub 2014 Jul 9. Semin Respir Crit Care Med. 2014. PMID: 25007087

10

Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis.

Braam AW, de Haan SN, Vorselaars AD, Rijkers GT, Grutters JC, van den Elshout FJ, Korenromp IH. Braam AW, et al. Among authors: korenromp ih. Brain Behav Immun. 2013 Oct;33:57-64. doi: 10.1016/j.bbi.2013.05.006. Epub 2013 May 29. Brain Behav Immun. 2013. PMID: 23727274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page